Healix

Long-Term Safety Analysis of Vedolizumab for Treatment of Crohn’s Disease and Ulcerative Colitis

Authors:
Timothy E. Ritter, MD – Texas Digestive Disease Consultants, PA, Southlake, TX
Chris Fourment, MD – Texas Digestive Disease Consultants, PA, Southlake, TX;
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
Thomas C. Hardin, PharmD, – Healix Infusion Therapy, Inc., Sugar Land, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound